Acinetobacter baumannii has emerged as an important nosocomial pathogen, particularly
for patients in intensive care units and with invasive indwelling devices. The most recent …

Pseudomonas aeruginosa infections are becoming increasingly difficult to treat due to
intrinsic antibiotic resistance and the propensity of this pathogen to accumulate diverse …

Immune systems restrict microbial pathogens by identifying" non-self" molecules called
microbe-associated molecular patterns (MAMPs). It is unclear how immune responses are …

Acinetobacter baumannii is a Gram-negative bacterial pathogen notorious for causing
serious nosocomial infections that resist antibiotic therapy. Research to identify factors …

Acinetobacter baumannii is a nosocomial pathogen of increasing importance due to its
multiple resistance to antibiotics and ability to survive in the hospital environment linked to …

Antibiotic-resistant Acinetobacter baumannii causes infections that are extremely difficult to
treat. A significant role in these resistance profiles is attributed to multidrug efflux pumps …

The opportunistic pathogen Acinetobacter baumannii is able to persist in the environment
and is often multidrug resistant (MDR), causing difficulties in the treatment of infections …

Multidrug-resistant (MDR) Acinetobacter baumannii strains can cause severe infections in
intensive care units, and are rapidly develo** resistance to the last-resort of existing …

Background A giant protein called BAP (biofilm-associated protein) plays a role in biofilm
formation and adhesion to host cells in A. baumannii. Most of the protein is made by arrays …

Acinetobacter baumannii has become one of the most challenging pathogens in many
countries with limited treatment options available. Cefiderocol, a novel siderophore …